About the Role
This role is about developing and executing the market access and pricing strategy for Galderma's Therapeutic Dermatology portfolio across the UK and Ireland. You will lead a team, manage payer relationships, and ensure successful patient access to critical treatments like Nemolizumab, while also building foundations for future pipeline success.
Responsibilities
- Lead a team of Regional Access Managers.
- Take full ownership of access, pricing, and reimbursement strategy across the UK and Ireland.
- Cement Nemolizumab's position following NICE positive guidance.
- Deepen formulary uptake for Nemolizumab.
- Strengthen relationships with NHS England, ICBs, and hospital stakeholders.
- Ensure reimbursement wins translate into commercial trajectory.
- Build access foundations, including stakeholder networks, commercial frameworks, and evidence programs, for future pipeline success.
- Plan lifecycle strategy, evidence generation, indication expansion, and early access programs.
- Report to the Global Head of Market Access and Pricing.
- Work closely with cross-functional teams locally and internationally.
- Navigate complex, ambiguous challenges and shape outcomes with strategic autonomy.
Requirements
- Substantial UK market access experience.
- Track record in biologic or specialty medicine reimbursement.
- Leadership experience managing market access teams in the UK pharmaceutical or biotech sector.
- Deep knowledge of NICE processes.
- Deep knowledge of NHS commissioning.
- Deep knowledge of the Scottish and Irish HTA and reimbursement environment.
- Familiarity with ABPI Code of Practice.
Location
- London
Work Type
- Full-time
Experience Level
- Leadership experience
Education Level
- Master's degree in Life Sciences, Health Economics, Pharmacy, or a related field
About the Company
- Galderma is the emerging pure-play dermatology category leader, present in approximately 90 countries.
- We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.
- Since our foundation in 1981, we have dedicated our focus and passion to the human body's largest organ - the skin - meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals.
- We are advancing dermatology for every skin story.
- We aim to empower each employee and promote their personal growth while ensuring business needs are met now and into the future.
- Across our company, we embrace diversity and respect the dignity, privacy, and personal rights of every employee.
- At Galderma, we actively give our teams reasons to believe in our bold ambition to become the leading dermatology company in the world.
- With us, you have the ultimate opportunity to gain new and challenging work experiences and create an unparalleled, direct impact.
- As the world's largest pure-play dermatology company, we are building something distinctive – a prescription portfolio in Therapeutic Dermatology where Nemolizumab is the flagship today, and where Galderma's ambitions in this space are still taking shape.
Equal Opportunity
- Across our company, we embrace diversity and respect the dignity, privacy, and personal rights of every employee.
